Chemotherapy after PD-1 inhibitors in relapsed/refractory Hodgkin lymphoma: Outcomes and clonal evolution dynamics.
Calabretta E, Guidetti A, Ricci F, Di Trani M, Monfrini C, Magagnoli M, Bramanti S, Maspero D, Morello L, Merli M, Di Rocco A, Graudenzi A, Derenzini E, Antoniotti M, Rossi D, Corradini P, Santoro A, Carlo-Stella C.
Calabretta E, et al. Among authors: antoniotti m.
Br J Haematol. 2022 Jul;198(1):82-92. doi: 10.1111/bjh.18183. Epub 2022 Apr 25.
Br J Haematol. 2022.
PMID: 35468225
Free PMC article.